These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21145422)

  • 21. Barrett's esophagus.
    Byrd D; McKinley MJ; Floch MH; Nair S
    Gastroenterologist; 1994 Jun; 2(2):160-5. PubMed ID: 8055240
    [No Abstract]   [Full Text] [Related]  

  • 22. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.
    Cameron AJ; Ott BJ; Payne WS
    N Engl J Med; 1985 Oct; 313(14):857-9. PubMed ID: 4033716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adenocarcinoma in Barrett's esophagus].
    Ovaska J; Miettinen M; Kivilaakso E
    Duodecim; 1989; 105(10):916-9. PubMed ID: 2766966
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis and recognition of early esophageal neoplasia.
    Herszényi L; Pregun I; Tulassay Z
    Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.
    Dent J
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():11-30. PubMed ID: 21199510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Section I: epidemiological review.
    Lukanich JM
    Semin Thorac Cardiovasc Surg; 2003 Apr; 15(2):158-66. PubMed ID: 12838486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical treatment of Barrett's esophagus: can it prevent cancer?
    Sampliner RE
    Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus.
    Achkar E; Carey W
    Am J Gastroenterol; 1988 Mar; 83(3):291-4. PubMed ID: 3125739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Esophagoscopic monitoring of Barrett's esophagus--additional life years of good quality or wasting of limited resources?].
    Voutilainen M
    Duodecim; 2010; 126(5):507-14. PubMed ID: 20597303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.
    Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG
    Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246
    [No Abstract]   [Full Text] [Related]  

  • 31. Barrett's esophagus and cytokine polymorphisms-confusion about the content in the abstract/results section compared to the table given in a recent manuscript.
    Leodolter A
    Am J Gastroenterol; 2005 Dec; 100(12):2814. PubMed ID: 16393242
    [No Abstract]   [Full Text] [Related]  

  • 32. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
    Corey KE; Schmitz SM; Shaheen NJ
    Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
    Lassen A; Hallas J; de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
    Provenzale D; Schmitt C; Wong JB
    Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta analysis: Cancer risk in Barrett's oesophagus.
    Thomas T; Abrams KR; De Caestecker JS; Robinson RJ
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1465-77. PubMed ID: 17900269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia.
    Donnellan F; Harewood GC; Patchett SE
    Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322
    [No Abstract]   [Full Text] [Related]  

  • 40. Barrett's esophagus-is it bad for your health?
    Falk GW
    Am J Gastroenterol; 2005 Dec; 100(12):2622-3. PubMed ID: 16393210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.